General Electric Medical Systems to market Surgi-Vision MRI coils:
This article was originally published in Clinica
General Electric Medical Systems (GEMS) will market and distribute MRI coils from two-year-old Surgi-Vision - an emerging technology company marketing novel imaging products developed at Baltimore, Maryland-based Johns Hopkins University department of radiology. Surgi-Vision, of Columbia, Maryland, got FDA 510(k) clearance for its oesophageal and aortic coil last September. GEMS plans to market the device alongside its GE Signa MRI scanner. Later products from Surgi-Vision are planned to image the heart, urethra and prostate gland.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.